PCR.smart™ is a compact platform for molecular diagnostics in qPCR, PCR, LAMP. The device performs isolation, amplification, detection and interpretation of sample results (any biological material containing DNA) in a few simple steps. All this in an extremely compact casing and using patented technology, guaranteeing results in up to 90 minutes, taking into account the entire process from sample preparation, through isolation, amplification and result interpretation. Areas of application: food safety, veterinary, water testing, modern agriculture, technological prevention for insurance market.
| Website | http://bioaccure.com |
| Employees | 6 (3 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Molecular Diagnostics, Dna Testing, Point Of Care Diagnostics, In Vitro Diagnostics, Disease Detection, Pcr Technology, Genetic Testing, Genetic Analysis, Sample Preparation, Diagnostic Equipment, Biological Sample Analysis, Biosensors, Medical Devices, Lab Automation |
| Competitors | Thermo Fisher Scientific, Novartis, Pfizer, GSK, Amgen, Regeneron, Biogen, Receptos, a wholly-owned subsidiary of Celgene, Veracyte, Inc., Genomatix AG +31 more (view full list) |
Looking for a particular Bioaccure employee's phone or email?
Aleksander Sienkiewicz is the CEO of Bioaccure.
3 people are employed at Bioaccure.